StockData
AnaptysBio, Inc logo

AnaptysBio, Inc (ANAB) stock

ANABNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 9/30
$49.24+2.63 (+5.64%)

Close on Oct 19, 2026Market cap $2.28BP/E –Yield –

AnaptysBio total assets

Total assets on the balance sheet at the end of each period.

AnaptysBio's total assets was $316.98M at Jun 30, 2026. For fiscal 2025 it was $364.40M, down 24.7% from the year before. The highest annual figure on record is $643.07M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$364.40M-24.7%
FY2024Dec 31, 2024$483.83M+7.0%
FY2023Dec 31, 2023$452.39M-25.9%
FY2022Dec 31, 2022$610.38M-5.1%
FY2021Dec 31, 2021$643.07M+54.4%
FY2020Dec 31, 2020$416.55M-4.3%
FY2019Dec 31, 2019$435.20M-14.5%
FY2018Dec 31, 2018$509.00M+54.5%
FY2017Dec 31, 2017$329.36M+429.7%
FY2016Dec 31, 2016$62.18M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$316.98M-5.4%
Q1 FY2026Mar 31, 2026$329.68M-21.9%
Q4 FY2025Dec 31, 2025$364.40M-24.7%
Q3 FY2025Sep 30, 2025$353.10M-28.4%
Q2 FY2025Jun 30, 2025$335.25M-21.6%
Q1 FY2025Mar 31, 2025$422.05M+4.0%
Q4 FY2024Dec 31, 2024$483.83M+7.0%
Q3 FY2024Sep 30, 2024$493.42M+1.3%
Q2 FY2024Jun 30, 2024$427.38M-17.4%
Q1 FY2024Mar 31, 2024$405.84M-26.5%
Q4 FY2023Dec 31, 2023$452.39M-25.9%
Q3 FY2023Sep 30, 2023$487.33M-21.2%
Q2 FY2023Jun 30, 2023$517.10M-14.4%
Q1 FY2023Mar 31, 2023$551.79M-11.7%
Q4 FY2022Dec 31, 2022$610.38M-5.1%
Q3 FY2022Sep 30, 2022$618.50M+45.8%
Q2 FY2022Jun 30, 2022$603.85M+41.6%
Q1 FY2022Mar 31, 2022$625.17M+57.7%
Q4 FY2021Dec 31, 2021$643.07M+54.4%
Q3 FY2021Sep 30, 2021$424.34M+10.3%
Q2 FY2021Jun 30, 2021$426.57M+6.2%
Q1 FY2021Mar 31, 2021$396.42M-6.6%
Q4 FY2020Dec 31, 2020$416.55M-4.3%
Q3 FY2020Sep 30, 2020$384.75M-14.8%
Q2 FY2020Jun 30, 2020$401.75M-16.3%
Q1 FY2020Mar 31, 2020$424.23M-14.2%
Q4 FY2019Dec 31, 2019$435.20M-14.5%
Q3 FY2019Sep 30, 2019$451.51M-13.7%
Q2 FY2019Jun 30, 2019$480.15M+56.9%
Q1 FY2019Mar 31, 2019$494.23M+57.0%
Q4 FY2018Dec 31, 2018$509.00M+54.5%
Q3 FY2018Sep 30, 2018$523.12M+329.0%
Q2 FY2018Jun 30, 2018$306.02M+134.7%
Q1 FY2018Mar 31, 2018$314.84M+140.1%
Q4 FY2017Dec 31, 2017$329.36M+429.7%
Q3 FY2017Sep 30, 2017$121.95M–
Q2 FY2017Jun 30, 2017$130.41M–
Q1 FY2017Mar 31, 2017$131.11M–
Q4 FY2016Dec 31, 2016$62.18M–

More AnaptysBio figures

See a number that looks wrong?